DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Lowered to $8.00 at Craig Hallum
DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) had its price target trimmed by Craig Hallum from $11.00 to $8.00 in a report issued on Thursday, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Oppenheimer reiterated an outperform rating and issued a $6.00 target price (down previously from $7.00) on shares of […]
More Stories
State Department Has Revoked 85,000 Visas Since January, Official Says
By Jacob Burg The Trump administration has rescinded 85,000 visas across all categories since President Donald Trump’s inauguration in January,...
More Than 100 Cases of Norovirus Reported on Cruise Ship: CDC
By Jack Phillips A norovirus outbreak has sickened more than 100 people on an Aida Cruises ship, according to an...
Student Sues North Carolina School District After Tribute to Charlie Kirk Is Censored
By Tom Ozimek A North Carolina high school student and her parents have sued the Charlotte-Mecklenburg Board of Education, alleging...
Trump Warns ‘Biggest Threat’ to US Would Be Supreme Court Overruling Tariffs
By Jack Phillips President Donald Trump on Tuesday said that national security could be at risk if the Supreme Court...
Federal Reserve Poised to Cut Interest Rates at Final Meeting of 2025
By Andrew Moran The Federal Reserve’s final policy meeting of the year is expected to end with an interest rate...
Will Japanese Series, The Fragrant Flower Blooms With Dignity, Return for Season 2?
The Japanese animated drama, The Fragrant Flower Blooms With Dignity, is getting praised by many viewers from around the world....